BPC-157 Peptide Technical Documents: COA, HPLC, LC-MS and Batch Review

Direct answer

A BPC-157 document review should connect the product identity, specification, batch number and analytical records before any individual purity value is accepted. For the currently published BPC-157 batch LJB2026050401, the available document set includes a Certificate of Analysis (COA), HPLC record, LC-MS record and product specification. These files should be reviewed together because each answers a different question.

The specification defines the expected attributes and acceptance criteria. The COA reports results for the identified batch. The HPLC record supports review of the chromatographic purity result, while LC-MS supports identity assessment through mass-related evidence. Matching the product name, CAS number, batch number, dates and reported results across the four records provides a clearer review trail than relying on a catalog purity statement alone.

BPC-157 identity and specification baseline

The following product information provides the baseline against which the batch documents should be checked. Buyers should use the supplied product form and current applicable specification for their own review rather than treating a general web description as a release decision.

Field	Current product information	Document review point
Product	BPC-157 peptide raw material	Use the same product designation across the specification, COA and analytical files.
CAS number	137525-51-0	Confirm that the CAS number refers to the intended material and is consistent wherever it is stated.
Molecular formula	C62H98N16O22	Use together with the sequence and molecular weight during identity review.
Molecular weight	1419.56 g/mol	Compare with the identity information and interpretation supplied with the LC-MS record.
Sequence	Gly-Glu-Pro-Pro-Pro-Gln-Pro-Ala-Pro-Pro-Val-Ala-Pro-Pro-Gly	Confirm that sequence-related records refer to the same 15-amino-acid peptide.
Purity specification	≥98.0% by HPLC	Compare the acceptance criterion with the batch COA and the supporting chromatographic record.
Storage information	Published for the supplied lyophilized form on the product page	Confirm the applicable condition on the current label, specification and shipment documentation.
Testing support	Third-party laboratory testing supported	Confirm the requested test scope, sample identity and reporting arrangement for the actual order.

Current BPC-157 batch document set

The following records are publicly available for technical review. All four records identify batch LJB2026050401 and were reviewed on May 4, 2026. Buyers should still confirm that the batch offered for a transaction is the same batch represented by the documents.

Document	Batch	Primary review purpose	File
Certificate of Analysis	LJB2026050401	Compare the reported batch results with the specification and verify product and batch identification.	View BPC-157 COA
HPLC	LJB2026050401	Review the chromatogram and reported purity result in relation to the COA and method information.	View BPC-157 HPLC
LC-MS	LJB2026050401	Review mass-related evidence supporting the identity assigned to the batch.	View BPC-157 LC-MS
Specification	LJB2026050401	Identify the attributes, methods and acceptance criteria used to evaluate the batch.	View BPC-157 Specification

Step 1: confirm document identity and batch linkage

Begin with the identifiers, not the reported result. The product name and batch number should be consistent across the COA, HPLC, LC-MS and specification. Where the CAS number, sequence, molecular formula or molecular weight is stated, compare it with the intended BPC-157 material.

Also check the issuing or testing entity, report number, sample identifier, test date, review date and page count where available. A chromatogram or spectrum without a clear link to the COA batch cannot independently establish that it represents the material being offered.

Step 2: compare the specification with the COA

The specification states what is tested and the applicable acceptance criteria. The COA reports the result assigned to a particular batch. Review the documents side by side and confirm:

• the test names and units use the same meaning;
• the reported method or method reference corresponds to the specification;
• each required result is present and clearly reported;
• the acceptance criterion has not been replaced by a catalog description;
• the batch disposition or conclusion follows the listed results;
• dates, signatures or review controls are complete where the document format requires them.

If the buyer has a separate internal specification, differences should be identified before purchase. A supplier result that meets one specification does not automatically meet a different buyer specification.

Step 3: read the HPLC record with the purity result

The current product specification states a purity criterion of at least 98.0% by HPLC. The corresponding HPLC record should be used to review the chromatographic evidence behind the batch result. Relevant checks include the sample and batch identifier, chromatographic conditions, detection information, retention data, peak table, integration and reported result.

An HPLC area percentage is method-specific. It should not automatically be interpreted as total peptide content, assay by mass or a complete account of every possible impurity. The value is most useful when the method, integration and reporting basis are understood and when the chromatogram can be linked to the same batch COA.

Step 4: use LC-MS for identity support

LC-MS provides mass-related evidence that can support the assigned identity of BPC-157. Review the expected molecular information, observed ions or deconvoluted mass where reported, charge-state interpretation and the link between the analyzed sample and batch LJB2026050401.

LC-MS and HPLC answer different questions. A mass result that supports identity does not by itself establish chromatographic purity, and an HPLC main peak does not by itself confirm the complete peptide identity. The two records should therefore be interpreted together with the specification and COA.

Step 5: review dates, versions and traceability

A complete review trail should show which specification version governed the batch, when the sample was tested and how the analytical records connect to the released COA. If a file is replaced or corrected, the revised version should be distinguishable from the earlier record.

Before shipment, confirm the actual available batch, quantity, material form, container or aliquot configuration, label, storage condition and destination requirements. Documents published for batch LJB2026050401 should not be represented as batch-specific evidence for another lot.

Questions to resolve before procurement

• Which BPC-157 batch is currently offered, and does it match the reviewed documents?
• What purity criterion and HPLC reporting basis apply to that batch?
• Are the COA, HPLC, LC-MS and specification linked by the same batch or sample identifier?
• Which additional tests or third-party testing arrangements are required by the buyer?
• What material form, quantity, packaging and aliquoting configuration are requested?
• Which storage and transport conditions apply to the supplied form?
• Which documents must accompany the shipment or internal quality review?
• What destination-market and import requirements must the buyer confirm?

Document-review warning signs

• the COA and analytical files show different batch or sample identifiers;
• a purity value is provided without the corresponding method or chromatographic record;
• the LC-MS record is presented as proof of purity rather than identity support;
• the specification and COA use different tests, units or acceptance criteria without explanation;
• dates, pages or report identifiers are incomplete or internally inconsistent;
• a document from one batch is used to represent another batch without clear disclosure;
• storage guidance for a different material form is substituted for the supplied product;
• certification or regulatory claims are made without current supporting evidence.

FAQ

Which documents are currently available for BPC-157 batch LJB2026050401?

The published set includes a COA, HPLC record, LC-MS record and specification. Each file should be checked against the batch offered for the actual transaction.

What does the BPC-157 COA show?

The COA reports batch-specific results. It should be read together with the governing specification and the supporting analytical records rather than used as a standalone catalog statement.

Does an HPLC purity result equal total peptide content?

Not necessarily. HPLC area percentage depends on the method, detection and integration basis and should not automatically be treated as assay by mass or a complete impurity balance.

Why are both HPLC and LC-MS reviewed?

HPLC supports chromatographic purity review, while LC-MS provides mass-related evidence supporting identity. Neither record replaces the other.

Can the documents for batch LJB2026050401 be used for another batch?

They may illustrate the available document format, but they are batch-specific evidence only for the identified batch. The offered lot requires its own applicable records.

What should a BPC-157 inquiry include?

Provide the required quantity, material form, target specification, testing and document needs, packaging or aliquoting requirements, destination and requested schedule.

Do these documents establish regulatory approval?

No. They support technical and quality review of the identified material and batch. The buyer remains responsible for determining registration, import and regulatory requirements in the destination jurisdiction.

Review the product and batch files

• BPC-157 product technical information
• Quality documentation support
• Submit a qualified BPC-157 B2B inquiry

For qualified B2B partners only. Not for personal use or direct consumer sale. Document availability, batch, quantity and supply details are confirmed for the actual inquiry.